Stock AnalizInteger Holdings Corp ITGR
Biotechnology: Electromedical & Electrotherapeutic Apparatus · data as of November 13, 2026
Integer Holdings Corp (ITGR) is a healthcare company listed in the US with a market value of about $4.3B. In the twelve months to October 2, 2026 it had revenue of $1.8B and net income of $104M, a net margin of 5.7%.
Its overall Stock Analiz score is 1.8 out of 5 (weak). The strongest part is financial health (3/5); the weakest is value (0/5).
Key numbers: a P/E of 42.7, a price to free cash flow of 52.6, 5-year revenue growth of 12% a year, a 5-year average ROIC of 5%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 67% below the current price.
Score: 1.8 / 5
Checks passed
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- 5-year revenue growth above 8% a year
- Profitable 5 years in a row
- Positive free cash flow
- Interest covered more than 5 times
- Liabilities below 60% of assets
- 20% to 100% of free cash flow returned to shareholders
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- Profit margin improving
- Strong R&D investment or growth above 20%
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.8B | $1.9B | $1.7B | $1.6B | $1.3B | $1.2B | $1.1B | $1.3B | $1.2B | $1.5B | $1.4B |
| Net income | $104M | $103M | $120M | $91M | $66M | $97M | $77M | $96M | $168M | $67M | $6M |
| Free cash flow | $82M | $105M | $100M | $60M | $42M | $103M | $135M | $117M | $122M | $102M | $47M |
| EPS (diluted) | $2.97 | $2.89 | $3.36 | $2.69 | $1.99 | $2.91 | $2.33 | $2.92 | $5.15 | $2.08 | $0.19 |
| Net margin | 5.7% | 5.5% | 7.0% | 5.8% | 5.0% | 7.9% | 7.2% | 7.7% | 13.8% | 4.6% | 0.4% |
| ROIC | — | 6.0% | 6.3% | 5.4% | 4.1% | 5.5% | 5.3% | 6.8% | 6.0% | 4.0% | 3.3% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 4 analysts is $127.00, 0% above the current price; targets range from $127.00 to $127.00; the consensus rating is “Hold”; expected EPS is $5.60 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Integer Holdings’s P/E ratio?
About 42.7, based on the last twelve months of diluted earnings per share (forward P/E about 19.7).
Is Integer Holdings stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 67% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Integer Holdings pay a dividend?
Not currently.
Is Integer Holdings a good stock to buy?
We do not give buy or sell advice. Integer Holdings scores 1.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.